CVE:EMH

Emerald Health Therapeutics Stock Forecast, Price & News

C$0.26
-0.01 (-3.77 %)
(As of 04/26/2021)
Add
Compare
Today's Range
C$0.25
C$0.27
50-Day Range
C$0.26
C$0.27
52-Week Range
C$0.15
C$0.53
Volume384,329 shs
Average Volume644,760 shs
Market CapitalizationC$52.28 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EMH News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.


Emerald Health Therapeutics logo

About Emerald Health Therapeutics

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.71 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Emerald Health Therapeutics (CVE:EMH) Frequently Asked Questions

What stocks does MarketBeat like better than Emerald Health Therapeutics?

Wall Street analysts have given Emerald Health Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Emerald Health Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Emerald Health Therapeutics' next earnings date?

Emerald Health Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, August 30th 2021.
View our earnings forecast for Emerald Health Therapeutics
.

How were Emerald Health Therapeutics' earnings last quarter?

Emerald Health Therapeutics, Inc. (CVE:EMH) released its quarterly earnings data on Monday, May, 31st. The company reported ($0.01) earnings per share (EPS) for the quarter. The company earned $2.26 million during the quarter.
View Emerald Health Therapeutics' earnings history
.

How has Emerald Health Therapeutics' stock been impacted by Coronavirus (COVID-19)?

Emerald Health Therapeutics' stock was trading at C$0.18 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EMH stock has increased by 41.7% and is now trading at C$0.26.
View which stocks have been most impacted by COVID-19
.

Who are Emerald Health Therapeutics' key executives?

Emerald Health Therapeutics' management team includes the following people:
  • Dr. Avtar S. Dhillon, Exec. Chairman (Age 59, Pay $485.05k)
  • Mr. Riaz Bandali M.B.A., CEO & Pres (Age 51, Pay $428.21k)
  • Ms. Jenn Hepburn B.B.A., CFO & Company Sec.
  • Mr. Orville Bovenschen, Sr. VP of Operations
  • Mr. Bernie Hertel, VP of Fin. and Communications
  • Ms. Rebecca Wong, Sr. VP of Quality & Regulatory Affairs

Who are some of Emerald Health Therapeutics' key competitors?

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), OrganiGram (OGI), (CGC) and Emerald Health Therapeutics (EMHTF).

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH."

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Emerald Health Therapeutics' stock price today?

One share of EMH stock can currently be purchased for approximately C$0.26.

How much money does Emerald Health Therapeutics make?

Emerald Health Therapeutics has a market capitalization of C$52.28 million and generates C$13.02 million in revenue each year.

How many employees does Emerald Health Therapeutics have?

Emerald Health Therapeutics employs 161 workers across the globe.

What is Emerald Health Therapeutics' official website?

The official website for Emerald Health Therapeutics is www.emerald.care.

Where are Emerald Health Therapeutics' headquarters?

Emerald Health Therapeutics is headquartered at 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada.

How can I contact Emerald Health Therapeutics?

Emerald Health Therapeutics' mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The company can be reached via phone at +1-250-8189838.


This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.